Status:
COMPLETED
A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Hypertension
Eligibility:
All Genders
6-16 years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy, safety, and toleration of eplerenone in the treatment of children aged 6 to 16 years with high blood pressure. The study will last approximately 10 weeks and about 320 patien...
Eligibility Criteria
Inclusion
- 6-16 years old male and female
- Systolic blood pressure greater than or equal to the 95th percentile for age, gender, and height, measured on at least 3 separate occasions
Exclusion
- K/DOQI classification of stages of chronic kidney disease equal to or greater than 3
- Serum or whole blood potassium \> 5.5 mEq/L
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00147589
Start Date
September 1 2004
End Date
January 1 2007
Last Update
December 22 2020
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Little Rock, Arkansas, United States
2
Pfizer Investigational Site
Beverly Hills, California, United States
3
Pfizer Investigational Site
Inglewood, California, United States
4
Pfizer Investigational Site
Los Angeles, California, United States